A case of aortic valve leaflet tear and perforations after neocuspidization
- PMID: 30775855
- PMCID: PMC6437436
- DOI: 10.1002/ehf2.12415
A case of aortic valve leaflet tear and perforations after neocuspidization
Abstract
Although aortic valve (AV) replacement is a curative procedure for severe aortic stenosis, prosthetic heart valves have many disadvantages and cause serious complications. A new promising surgical procedure-aortic valve neocuspidization (AVNeo)-has recently been developed; it is an original method of AV reconstruction with autologous pericardium. It has been reported to yield excellent medium-term results with respect to durability and complications. Herein, we encountered a first case of AV leaflet tear and perforations 27 months after AVNeo using autologous pericardium. AV leaflet tear or perforation is well recognized as a long-term serious complication of pericardial xenografts. Interestingly, however, AVNeo caused early structural valve deterioration in the current case. In the present case, an eccentric aortic regurgitation jet observed on colour flow imaging led us to reach the correct diagnosis. Finally, the patient showed complete recovery with redo AV replacement. This case highlights the importance of understanding the potential pitfalls of this new surgical technique and that of colour Doppler echocardiography in reaching a definite diagnosis.
Keywords: Aortic regurgitation; Aortic valve leaflet tear and perforations; Aortic valve neocuspidization using autologous pericardium; Colour Doppler echocardiography; Structural valve deterioration.
© 2019 The Authors ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.
Conflict of interest statement
None declared.
Figures
References
-
- Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice Guidelines . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: e57–e185. - PubMed
-
- Ozaki S, Kawase I, Yamashita H, Uchida S, Takatoh M, Kiyohara N. Midterm outcomes after aortic valve neocuspidization with glutaraldehyde‐treated autologous pericardium. J Thorac Cardiovasc Surg 2018; 155: 2379–2387. - PubMed
-
- Ozaki S, Kawase I, Yamashita H, Uchida S, Nozawa Y, Matsuyama T, Takatoh M, Hagiwara S. Aortic valve reconstruction using self‐developed aortic valve plasty system in aortic valve disease. Interact Cardiovasc Thorac Surg 2011; 12: 550–553. - PubMed
-
- Ozaki S, Kawase I, Yamashita H, Uchida S, Nozawa Y, Takatoh M, Hagiwara S. A total of 404 cases of aortic valve reconstruction with glutaraldehyde‐treated autologous pericardium. J Thorac Cardiovasc Surg 2014; 147: 301–306. - PubMed
-
- Yamashita H, Ozaki S, Iwasaki K, Kawase I, Nozawa Y, Umezu M. Tensile strength of human pericardium treated with glutaraldehyde. Ann Thorac Cardiovasc Surg 2012; 18: 434–437. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical